2022
DOI: 10.1016/j.redox.2022.102481
|View full text |Cite
|
Sign up to set email alerts
|

Tauroursodeoxycholic acid functions as a critical effector mediating insulin sensitization of metformin in obese mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
10
0
1

Year Published

2023
2023
2025
2025

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 46 publications
1
10
0
1
Order By: Relevance
“…However, the precise regulatory mechanism underlying fucoidan‐induced activation of the Nrf2/ARE signaling pathway remains unclear. In a previous study (Zhang, Cheng, et al, 2022), we revealed the intricate molecular mechanisms by which metformin activates Nrf2/ARE, which could serve as a reference for elucidating the pharmacological mechanism of SP‐Fuc. We found that metformin significantly increased the accumulation of tauroursodeoxycholic acid (TUDCA) by remodeling the gut microbiota, reducing the abundance of Bifidobacterium and the activity of bile salt hydrolase.…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…However, the precise regulatory mechanism underlying fucoidan‐induced activation of the Nrf2/ARE signaling pathway remains unclear. In a previous study (Zhang, Cheng, et al, 2022), we revealed the intricate molecular mechanisms by which metformin activates Nrf2/ARE, which could serve as a reference for elucidating the pharmacological mechanism of SP‐Fuc. We found that metformin significantly increased the accumulation of tauroursodeoxycholic acid (TUDCA) by remodeling the gut microbiota, reducing the abundance of Bifidobacterium and the activity of bile salt hydrolase.…”
Section: Discussionmentioning
confidence: 91%
“…However, the precise regulatory mechanism underlying fucoidan-induced activation of the Nrf2/ARE signaling pathway remains unclear. In a previous study (Zhang, Cheng, et al, 2022), we revealed the intricate molecular mechanisms by which metformin activates Nrf2/ARE, which could in a single-site, double-blind, randomized, placebo-controlled trial (Wright et al, 2019). Another clinical study (Sakai et al, 2019) conducted a double-blind, randomized, placebo-controlled, crossover trial in 30 patients with T2DM received high-molecular-weight fucoidan (1620 mg/day for 12 weeks).…”
Section: Discussionmentioning
confidence: 99%
“… 35 But different studies have different results regarding its regulation of blood sugar. Zhang et al 36 studied that in the ob/ob2 type diabetes mouse model, TCDCA alleviated IR, and reduced oxidative stress and intestinal inflammation. The mechanism of its action may be that TCDCA blocks the binding of KEAP1 and Nrf2, leading to Nrf2 translocation to the nucleus and initiating the transcription of antioxidant genes, ultimately reducing intracellular ROS accumulation and improving insulin signaling.…”
Section: Discussionmentioning
confidence: 99%
“…The lipid metabolism process in zebrafish, encompassing lipid absorption and transport, oxidative metabolism, and related processes, bears a striking resemblance to that of mammals [25], and it can also reveal the changes in lipid metabolism in fish. These benefits render zebrafish highly suitable models for investigating diseases associated with lipid metabolism, such as diabetes and NAFLD [26,27]. NAFLD is a metabolic disorder with multiple causes, long-term hyperglycemia causes macrovascular or microvascular complications, such as retinopathy [28].…”
Section: Introductionmentioning
confidence: 99%